Effects of calcitonin on patients with Paget's disease, thyrotoxicosis, or hypercalcaemia.
D000328:Adult; D000368:Aged; D002116:Calcitonin / Q000008:administration & dosage*; D002118:Calcium / Q000097:blood / Q000652:urine; D003404:Creatinine / Q000652:urine; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000097:blood / Q000652:urine; D006934:Hypercalcemia / Q000188:drug therapy*; D006980:Hyperthyroidism / Q000188:drug therapy*; D007275:Injections, Intravenous; D008274:Magnesium / Q000097:blood / Q000652:urine; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000188:drug therapy*; D010710:Phosphates / Q000097:blood; D011188:Potassium / Q000652:urine; D012964:Sodium / Q000652:urine
D010710:Phosphates; D002116:Calcitonin; D012964:Sodium; D003404:Creatinine; D008274:Magnesium; D006909:Hydroxyproline; D011188:Potassium; D002118:Calcium